Next-Generation Blood Solute Monitoring and Adaptive Dialysis System

A wearable, real-time blood solute monitoring system integrated with AI-driven adaptive dialysis therapy, enabling personalized and optimized treatment outcomes.

The original patent relates to systems and methods for utilizing a sorbent cartridge and quantifying chemistry changes to determine solute concentrations in dialysate. However, these systems have limitations in terms of real-time monitoring, adaptability, and precision. The new inventive concept addresses these limitations by introducing a wearable, miniaturized dialysate recirculation module, nanoscale sorbent cartridge, and machine learning-based analytics engine, enabling real-time monitoring and adaptive dialysis therapy.

The next-generation blood solute monitoring and adaptive dialysis system consists of a wearable, miniaturized dialysate recirculation module, a nanoscale sorbent cartridge integrated with a microfluidic sensor array, and a machine learning-based analytics engine. The system continuously monitors blood solute levels using the wearable module, dynamically adjusts dialysate composition and flow rates based on real-time analytics, and optimizes treatment outcomes using a cloud-based, AI-driven decision support system. The system also features an artificial intelligence-powered, autonomous sorbent cartridge management module, which predicts and prevents cartridge exhaustion, optimizes reagent usage, and ensures seamless treatment continuity.

The new inventive concept introduces a paradigm shift in dialysis therapy by integrating wearable, real-time monitoring with AI-driven adaptive therapy, enabling personalized and optimized treatment outcomes. The use of nanoscale sorbent cartridges, microfluidic sensor arrays, and machine learning-based analytics engines represents a significant departure from the original patent's limitations, providing a novel and non-obvious solution.

Alternative embodiments of the inventive concept may include implantable, wireless-enabled sensors, graphene-based electrochemical sensor arrays, or cloud-based analytics platforms. Variations of the system may also incorporate genomic and proteomic data integration, precision treatment planning, or iterative, real-time feedback mechanisms.

The next-generation blood solute monitoring and adaptive dialysis system has significant commercial potential in the dialysis therapy market, with potential applications in hospitals, clinics, and home care settings. The system's ability to provide personalized and optimized treatment outcomes, reduce treatment costs, and improve patient quality of life makes it an attractive solution for healthcare providers and patients alike.